MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis
- 19 December 2013
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 29 (1) , 121-127
Abstract
Background and Aim: Management of hepatitis C virus (HCV) recurrence is a major challenge after liver transplantation. Significant dysregulated expression of HCV receptors (i.e. claudin‐1, occludin, tetraspanin CD81, scavenger receptor type B1) has been shown recently during HCV infection. This might facilitate hepatocytic entry and reinfection of HCV. MicroRNAs (miRs) play role in the regulation of gene expression. We aimed to characterize miR expression profiles related to HCV infection and antiviral therapy in adult liver transplant recipients, with special emphasis on miRs predicted to target HCV receptors.Methods: Twenty‐eight adult liver transplant recipients were enrolled in the study. Paired biopsies were obtained at the time of HCV recurrence and at the end of antiviral treatment. MiRs for HCV receptors were selected using target prediction software. Expression levels of miR‐21, miR‐23a miR‐34a, miR‐96, miR‐99a*, miR‐122, miR‐125b, miR‐181a‐2*, miR‐194, miR‐195, miR‐217, miR‐221, and miR‐224 were determined by reverse transcription–quantitative polymerase chain reaction.Results: miR‐99a* and miR‐224 expressions were increased in HCV recurrence samples, while miR‐21 and miR‐194 were decreased in comparison to normal liver tissue. Increased expressions of miR‐221, miR‐224, and miR‐217 were observed in samples taken after antiviral therapy when compared with HCV recurrence samples. High HCV titer at recurrence was associated with higher level of miR‐122.Conclusions: Samples at recurrence of HCV and after antiviral therapy revealed distinct HCV‐related miR expression profiles, with significant dysregulation of those miRNAs potentially targeting mRNAs of HCV receptors. In particular, miR‐194 and miR‐21 might be involved in the regulation of HCV receptor proteins' expression during HCV infection and antiviral therapy.Keywords
Funding Information
- Hungarian National Scientific Research Foundation (OTKA K101435)
This publication has 39 references indexed in Scilit:
- MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseasesTranslational Research, 2011
- Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kineticsHepatology, 2010
- miR-194 Is a Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in MiceHepatology, 2010
- miR-221 overexpression contributes to liver tumorigenesisProceedings of the National Academy of Sciences, 2009
- Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic propertiesOncogene, 2009
- microRNA‐122 stimulates translation of hepatitis C virus RNAThe EMBO Journal, 2008
- Position-Dependent Function for a Tandem MicroRNA miR-122-Binding Site Located in the Hepatitis C Virus RNA GenomeCell Host & Microbe, 2008
- Interferon modulation of cellular microRNAs as an antiviral mechanismNature, 2007
- Cellular cofactors affecting hepatitis C virus infection and replicationProceedings of the National Academy of Sciences, 2007
- Dynamic regulation of miRNA expression in ordered stages of cellular developmentGenes & Development, 2007